Relationships between cigarette consumption and biomarkers of tobacco toxin exposure

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 12, 2005, Pages 2963-2968

  Joseph, Anne M ^a,b   Hecht, Stephen S ^b   Murphy, Sharon E ^b   Carmella, Steven G ^b   Le, Chap T ^b   Zhang, Yan ^b   Han, Shaomei ^b   Hatsukami, Dorothy K ^b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYPYRENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CORRELATION ANALYSIS; DATA ANALYSIS; DOSE RESPONSE; FEMALE; HEART DISEASE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; TOBACCO;

BIOLOGICAL MARKERS; CARBON MONOXIDE; COTININE; CROSS-SECTIONAL STUDIES; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROSAMINES; POLYCYCLIC HYDROCARBONS, AROMATIC; PYRIDINES; RANDOMIZED CONTROLLED TRIALS; SMOKING; URINALYSIS;

EID: 30444459959     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0768     Document Type: Article

References (22)

1. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Washington (DC): U.S. Government Printing Office; 2004.
2. Conn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation 2004;109:1V31-46.
3. Patel SN, Rajaram V, Pandya S, et al. Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep 2004;6:60-8.
4. Hecht SS. Carcinogen biomarkers for lung or oral cancer chemoprevention trials. IARC Sci Publ 2001;154:245-55.
5. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-related cancers. Oncogene 2002;21:7435-51.
6. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-210.
7. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
8. Hecht S, Murphy SE, Carmella SG, et al. Effects of reduced cigarette smoking on uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst 2004;96:107-15.
9. Hecht SS, Carmella SG, Le KA, et al. Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine. Cancer Epidemiol Biomarkers Prev 2004;13:834-42.
10. Jongeneelen FJ. Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann Occup Hyg 2001;45:3-13.
11. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
12. Hecht SS, Carmella SG, Chen M, et al. Quantification of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999;59:590-6.
13. Carmella SG, Akerkar S, Richie JP, Hecht SS. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev 1995;4:635-42.
14. Carmella SG, Le K, Hecht SS. Improved method for determination of 1-hydroxypyrene in human urine. Cancer Epidemiol Biomarkers Prev 2004;13:1261-4.
15. Hecht SS, Carmella SG, Murphy SE. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarkers Prev 1999;8:907-13.
16. Wall MA, Johnson J, Jacob P, Benowitz NL. Cotinine in the serum, saliva and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health 1988;78:699-701.
17. Murray RP, Connett JE, Lauger GG, Voelker HT. Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. Am J Public Health 1993;83:1251-7.
18. Waage H, Silsand T, Urdal P, Langard S. Discrimination of smoking status by thiocyanate and cotinine in serum, and carbon monoxide in expired air. Int J Epidemiol 1992;21:488-93.
19. Hecht SS, Murphy SE, Carmella SG, et al. Similar uptake of lung carcinogens by smokers of regular, light, and ultra-light cigarettes. Cancer Epidemiol Biomarkers Prev 2005;14:693-8.
20. Wen SW, KMS, Hoey J, Hanley JA, Usher RH. Terminal digit preference, random error, and bias in routine clinical measurement of blood pressure. J Clin Epidemiol 1993;46:1187-93.
21. Murphy SE, Link CA, Jensen J, et al. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiol Biomarkers Prev 2004;13:1617-23.
22. U.S. Environmental Protection Agency (EPA). Respiratory health effects of passive smoking: lung cancer and other disorders, USEPA, Document No. 600/6-90/006F; 1992.